With a robust foundation in sales, training, marketing, and operations, my tenure at Calliditas Therapeutics has been marked by pioneering the sales infrastructure for TARPEYO while leading the first product launch for IgA Nephropathy in the US. Originally launching via a Contract Sales Organization, the sales team had immediate success, which facilitated a rapid expansion and transition to an in-house sales force. This underscored our commitment to helping patients while driving the growth of our organization. We've experienced YOY growth since launch and continue to outpace forecast. Previously, at Kyowa Kirin, as National Sales Director, I honed my expertise in oncology and rare diseases, leading a diverse team towards successful portfolio sales. The success obtained through these experiences reflects a deep understanding of the intricacies of commercial strategy and development within the biotech and pharmaceutical landscapes.